We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Friday, August 16, 2024
With gene editing widely touted as the future of biotechnology, seed trait developers are looking for ways to show they are using the technology responsibly.
USDA, EPA and FDA announced a joint plan Wednesday that lays out steps the agencies are taking to further streamline the regulation of genetically modified plants, animals and microorganisms.
The European Union appears ready to facilitate approval of gene-edited crops and usher in a new era on the continent, one where plants created using “new genomic techniques” (NGTs) are no longer substantially barred from production.
Cibus, a gene editing technology company, says it has completed what it believes is the first regeneration of wheat from a single cell, offering new possibilities for innovation in the global staple crop.
Biotech plant developers are pleased with a proposal from the Animal and Plant Health Inspection Service to create five new regulatory exemptions for genetically modified plants.
A European Commission (EC) draft proposal could lead to a loosening of regulations long criticized by plant breeders as inhospitable to new genetic engineering techniques such as gene editing.
Speakers at a recent White House listening session pleaded with the Biden administration to modernize U.S. regulatory oversight of gene-edited plant products to compete with other countries that have streamlined processes allowing for quicker approval.
Gene-edited fruits, vegetables and other specialty crops are likely to hit the market in increasing numbers over the next five years to meet consumer demand for improved traits, according to a report by Rabobank.
The Food and Drug Administration for the first time cleared the marketing of products from a biotech food animal, approving beef cattle that are genetically altered to be more tolerant of hot weather.
President Joe Biden has chosen Robert Califf to lead the Food and Drug Administration, which would give the cardiologist and professor a second stint at the agency's helm.